Search results
Sandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our partnerships and collaborations.
Sandoz
www.sandoz.com is the official website of Sandoz, a global leader in generic and biosimilar medicines, and a division of Novartis. Find out more about the company's history, vision, and products.
In 2009, Sandoz acquired EBEWE Pharma's specialty generic injectables division and in 2010, acquired Oriel Therapeutics. In 2012, Sandoz acquired Fougera Pharmaceuticals, entering the generic (topical) dermatology business.
Oct 4, 2023 · Novartis today completed the Spin-off of Sandoz, its Generics and Biosimilars business, through a dividend-in-kind distribution to holders of Novartis shares and American Depositary Receipts (ADRs), with each holder receiving one Sandoz share for every five Novartis shares or one Sandoz ADR for every five Novartis ADRs, held at the close of ...
Learn about Sandoz, a global leader in generic and biosimilar medicines, and a division of Novartis. Discover our mission, vision, and values.
Sandoz US is a leading company in generic and biosimilar medicines, dedicated to improving and extending people's lives. Find out more about our products, locations and contact information.